Divergent Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-135
Closed -$6K 104
2018
Q3
$6K Hold
135
﹤0.01% 117
2018
Q2
$5K Sell
135
-34
-20% -$1.16K ﹤0.01% 116
2018
Q1
$6K Buy
+169
New +$5.81K ﹤0.01% 117

Other funds holding PFE

Divergent Wealth Advisors's PFE Position: Q4 2018 in Review

Divergent Wealth Advisors sold out of Pfizer (PFE) in Q4 2018, closing a stake of 135 shares — an estimated $6K sold.

Divergent Wealth Advisors first reported a position in PFE in Q1 2018 and held it in 3 quarters. The position peaked at $6K in Q3 2018. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Divergent Wealth Advisors reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Divergent Wealth Advisors sold 135 Pfizer shares in Q4 2018, an estimated $6K.
  • Divergent Wealth Advisors first reported a position in Pfizer in Q1 2018 and held it in 3 quarters.
  • Divergent Wealth Advisors's Pfizer position peaked at $6K in Q3 2018.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Divergent Wealth Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.